Patent Assignment
Reel/Frame 052467/0650
Assignment of Assignor's Interest
Recorded: 2020-04-22
Pages: 10
Assignors
CHAND, POORAN
Executed: 2018-10-11
GUPTA, YOGESH KUMAR
Executed: 2018-10-11
KUMAWAT, RAKESH KUMAR
Executed: 2018-10-11
ALHAMADSHEH, MAMOUN
Executed: 2018-10-11
ZAMBONI, ROBERT
Executed: 2019-03-22
Assignee
EIDOS THERAPEUTICS, INC.
101 MONTGOMERY STREET, 20TH FLOOR, SAN FRANCISCO, CALIFORNIA, 94104
Covered Property
(1)
Processes for Preparing Ag-10, Its Intermediates, and Salts Thereof
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Nov 17, 2021
From: BRIDGEBIO PHARMA, INC.; ORIGIN BIOSCIENCES, INC.; EIDOS THERAPEUTICS, INC.; QED THERAPEUTICS, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 058144/0302 →
Security Interest
Jan 17, 2024
From: EIDOS THERAPEUTICS, INC.
To: ALTER DOMUS (US) LLC, AS COLLATERAL AGENT
Reel/Frame 066155/0019 →
Security Interest
Jan 17, 2024
From: CALCILYTIX THERAPEUTICS INC.; ADRENAS THERAPEUTICS INC.; PHOENIX TISSUE REPAIR, INC.; NAVIRE PHARMA, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066342/0154 →
Release of Security Interest
Jan 18, 2024
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS SUCCESSOR TO U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: BRIDGEBIO PHARMA, INC.; ORIGIN BIOSCIENCES, INC.; EIDOS THERAPEUTICS, INC.; QED THERAPEUTICS, INC.
Reel/Frame 066167/0462 →
Security Interest
Jan 19, 2024
From: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; THERAS, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066355/0126 →
Release of Security Interest in Patent Collateral
Mar 5, 2025
From: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; ML BIO SOLUTIONS INC.
Reel/Frame 070551/0095 →